e-learning
resources
Copenhagen 2005
Monday 19.09.2005
Pulmonary hypertension and fibrosis: novel mechanisms
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Targeted adenoviral gene transfer of wild type (wt) BMPR2 attenuates hypoxic pulmonary hypertension
A. M. Reynolds, M. D. Holmes, D. T. Curiel, P. N. Reynolds (Adelaide, Australia; Birmingham, United States Of America)
Source:
Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Session:
Pulmonary hypertension and fibrosis: novel mechanisms
Session type:
Oral Presentation
Number:
1619
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. M. Reynolds, M. D. Holmes, D. T. Curiel, P. N. Reynolds (Adelaide, Australia; Birmingham, United States Of America). Targeted adenoviral gene transfer of wild type (wt) BMPR2 attenuates hypoxic pulmonary hypertension. Eur Respir J 2005; 26: Suppl. 49, 1619
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Targeted gene delivery of BMPR2 attenuates pulmonary hypertension
Source: Eur Respir J 2012; 39: 329-343
Year: 2012
Alveolar type 2 cell dysfunction from expression of a surfactant protein C (SFTPC) mutation drives a fibrotic lung phenotype in mice
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
The effects of chronic hypoxia on pulmonary vascular reactivity in mice genetically deficient in connexin 43
Source: International Congress 2017 – Experimental PH
Year: 2017
Intratracheally administered recombinant adenovirus carrying a novel mutated IκBα gene abrogates pulmonary eosinophil inflammation in a murine asthma model
Source: Eur Respir J 2006; 28: Suppl. 50, 225s
Year: 2006
Decreased expression of the TGF-beta type I receptor ALK1 in pulmonary arterial hypertension
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
Gene expression alterations in mice lacking the VIP gene are conducive to pulmonary arterial hypertension and pulmonary vascular remodeling
Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension
Year: 2007
A helper-dependent adenoviral vector rescues CFTR to wild-type functional levels in cystic fibrosis epithelial cells harbouring class I mutations
Source: Eur Respir J, 56 (5) 2000205; 10.1183/13993003.00205-2020
Year: 2020
Effect of eNOS gene overexpression on the vascular reactivity of isolated pulmonary arteries of chronic hypoxic rats
Source: Annual Congress 2006 - Taormina 4th ERS Lung Science Conference "hypoxia in lung biology and disease"
Year: 2006
Mice over-expressing the 5-HT transporter gene develop pulmonary hypertension
Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Year: 2004
The inhibition of MRP4, a new target in pulmonary hypertension (PH), prevents and reverses hypoxia-induced pH in mice
Source: Annual Congress 2009 - Pathobiology of pulmonary hypertension
Year: 2009
Microarray analysis of pulmonary gene expression in mice lacking the vasoactive intestinal peptide (VIP) gene: confirmation of a role in asthma and pulmonary arterial hypertension (PAH)
Source: Annual Congress 2006 - Cellular mechanisms of airway disease
Year: 2006
Vascular remodeling in the lung from mice treated with monocrotaline. The effect of protein C inhibitor transgenic expression
Source: Eur Respir J 2006; 28: Suppl. 50, 823s
Year: 2006
Development of pulmonary fibrosis in conditional Nedd4-2 deficient mice
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Hypoxia-induced miR-130a is a novel repressor of BMPR2 gene expression in experimental pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: basic mechanisms
Year: 2012
Targeting bone morphogenic protein receptor 2 (BMPR2) signalling to treat pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701370; 10.1183/13993003.01370-2017
Year: 2017
Disruption of Nrf2 enhances susceptibility to pulmonary fibrosis induced by bleomycin in mice
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011
Overexpression of angiotensin II type 1 receptor (AGTR1) and lymphatic vasculature rarefaction is present in scleroderma with pulmonary compromised
Source: Annual Congress 2012 - Diffuse parenchymal lung disease II
Year: 2012
Enhancement of pulmonary vascular remodelling and inflammatory genes with VIP gene deletion
Source: Eur Respir J 2008; 31: 135-139
Year: 2008
Pulmonary arterial hypertension phenotype in VIP knockout mice
Source: Eur Respir J 2006; 28: Suppl. 50, 546s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept